newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence

DUBLIN and CHICAGO, June 25, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM) (the "Company" or "Iterum"), a company focused on delivering next generation oral and IV antibiotics to treat infections